Two endocytic receptors, the low density lipoprotein (LDL) receptor (LDLR) and the LDLR-related protein (LRP) (7), and placed on ice. At the end of experiments, the abdominal cavity was exposed via a midline incision and a blood sample was drawn from the inferior vena cava. The portal vein was then cannulated with a 21-gauge needle, which was tied in place. The vena cava above the liver was then incised and the liver was flushed with 3 ml of cold 0.15 M NaCl under a pressure of 50 cm of water.
mice after 30 min, consistent with blockade of the slow endocytosis by a RAP-sensitive process. Taken together with previous studies, our results are consistent with a model in which the initial hepatic removal of chylomicron remnants is primarily mediated by mechanisms that do not include LDLR or LRP, possibly involving glycosaminoglycan-bound hepatic lipase and apolipoprotein E. After the remnants bind to these alternative sites on the hepatocyte surface, endocytosis is predominantly mediated by the LDLR and also by a slower and less efficient backup process that is RAP sensitive and therefore most likely involves LRP.
Chylomicron remnants are derived from lymph chylomicrons that carry dietary fat and cholesterol into the blood. Chylomicron remnants are produced in extrahepatic tissues by hydrolysis of component triglycerides and some phospholipids by lipoprotein lipase, and after entering the liver are taken up into parenchymal cells by receptor-mediated endocytosis (1). Previous observations and experiments have strongly suggested that this process involves at least two receptors on the surface of hepatocytes (1, 2). Binding of the remnants to these receptors is mediated by apolipoprotein E (apoE) (1, 3). One of the receptors thought to be involved in remnant uptake is the low density lipoprotein (LDL) receptor (LDLR), which strongly binds apoE. Considerable indirect evidence suggests that another is the LDLR-related protein (LRP), which mediates the cellular uptake of apoE-enriched remnant lipoproteins (4) .
LRP is a multifunctional protein that also binds a2-macroglobulin and a variety of other macromolecules (5) . Its role in cellular lipoprotein metabolism has been investigated in great detail, but the physiological importance of this function
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has been difficult to evaluate in vivo because mouse embryos lacking LRP die in utero (6) . LDLR-deficient [LDLR (-/-)] mice, in contrast, develop normally and do not accumulate large amounts of chylomicron remnants (7) , consistent with observations in LDLR-deficient rabbits (8) and humans (9) .
To dissect the respective contributions of LDLR and LRP to the removal of chylomicron remnants by the liver, we have in previous studies (10, 11) (10) , which binds RAP with lower affinity than LRP (10) . Therefore it was impossible to determine whether the blockade of endocytosis of the chylomicron particles by RAP was a result of binding to the LDLR, LRP, or both. In these rat experiments, RAP caused only partial inhibition of the clearance of the chylomicron particles by the liver, consistent with other data that the initial removal of chylomicron remnants by the liver is mediated by interaction with other macromolecules, such as hepatic lipase (1, 13), or by interaction with apoE bound to extracellular proteoglycans (13) (14) (15) .
In another study Willnow et (16) . Chylomicrons were separated from lymph serum by ultracentrifugation and used within 48 h. Human a2-macroglobulin was prepared and activated with 200 mM methylamine, and then radioiodinated as described (10) . Bacterial glutathione S-transferase (GST) and fusion protein of GST with rat 39-kDa LRP-associated protein (GST-RAP) were prepared as described (17) .
Mice and Experimental Protocols. LDLR-"knockout" mice [LDLR (-/-)] were created from hybrids of C57BL/6J and 129SvJ strains as described (7) . Control (7), and placed on ice. At the end of experiments, the abdominal cavity was exposed via a midline incision and a blood sample was drawn from the inferior vena cava. The portal vein was then cannulated with a 21-gauge needle, which was tied in place. The vena cava above the liver was then incised and the liver was flushed with 3 ml of cold 0.15 M NaCl under a pressure of 50 cm of water.
The liver was then removed and weighed. A mixed endosome fraction was prepared by minor modifications of methods developed for rat liver (18) . Two livers were pooled and homogenized in 0.5 M sucrose, and an endosome-enriched subcellular fraction was obtained after several steps by centrifugation in a Percoll gradient. This material was diluted with 2 vol of 0.15 M NaCI, and the endosomes were obtained by centrifugation onto a sucrose cushion. The fluffy white material just above the sucrose cushion was harvested with a Pasteur pipette, resuspended in 0.15 M NaCl, and recentrifuged as above. The purified endosomes were again harvested from just above the sucrose cushion for analysis. Their appearance by electron microscopy closely resembled that shown previously for hepatocytic endosomes from rats (18) . At each step of the fractionation procedure, samples were taken for analysis of 3H.
Analysis. Lipids were extracted from samples of blood plasma, liver, and subcellular fractions into chloroform/ methanol (19) and 3H was estimated by liquid scintillation spectrometry in the extracts and in cholesterol and cholesteryl esters (CE) separated by thin-layer chromatography (20 (24) . Chromogenicity factors for human apoB-100 and apoB-48 (but not apoE) have been shown to apply to the rat proteins (24) . These chromogenicity factors were used here.
Calculations. Differences between experimental groups were evaluated by one-way ANOVA. Results are given as mean of n experiments ± SD.
RESULTS
LDLR (-/-) mice had increased levels of cholesterol in LDL, as reported previously (7), and also in IDL, but only a slight increase in VLDL-cholesterol (Table 1 ). The concentrations of apoB-100 and apoB-48 in VLDL of normal and LDLR (-/-) mice were similar. The total concentration of apoB-100 in plasma, however, was increased almost 4-fold, mainly in LDL, and that of apoB-48 was increased only about 1.4-fold, also mainly in LDL, with a lesser increase in IDL. The concentration of apoE was increased 2.5-fold, predominantly in the LDL and IDL fractions, with a minor increase in VLDL.
To determine the effectiveness of GST-RAP in blocking removal of activated a2-macroglobulin by the liver, the hepatic content of 125I was determined at intervals after intravenous injection of 125I-labeled a2-macroglobulin together with GST-RAP (1.5 mg) or an equimolar amount of GST (0.9 mg) into normal and LDLR (-/-) mice. Blockade by GST-RAP was >97% 20 min after injection (Table 2) . Hepatic uptake began after about 40 min and was extensive by 60 min (data not shown). In two experiments, mean recovery of 125I in hepatic endosomes 20 min after injection was 4.24% and 6.07% of that injected in normal and LDLR (-/-) mice given GST and 0.07% and 0.02%, respectively, in mice given GST-RAP.
In normal and LDLR (-/-) mice given GST (8) and humans (9) . As expected, LDLR (-/-) mice had grossly elevated concentrations of LDL and IDL. There was no appreciable increase in particle number in the VLDL fraction in these mice, as assessed from the concentration of apoB-100 and apoB-48. The VLDL were, however, enriched with cholesterol and apoE, suggesting a limited (16) . In LDLR-deficient rabbits, hepatogenous VLDL particles (greater than 500 A in diameter) containing apoB-100 are removed from the blood at a normal rate, whereas clearance of smaller VLDL is substantially impeded (27) . Smaller (-/-) mice, given the increased concentration of apoB-48 in their LDL.
As in normal rats (10) (4, 30) . Only after addition of exogenous apoE are P-VLDL, a remnant lipoprotein from cholesterol-fed rabbits, taken up by endocytosis via LRP and delivered to lysosomes (4) . ApoE is known to be concentrated on the sinusoidal surface of rat hepatocytes (14) . This raises the possibility that the additional apoE required for binding to LRP is acquired by chylomicron remnants after the particles bind to other sites at or near the cell surface (1, 4, 14) . Inhibition of cell surface hepatic lipase by specific antibody substantially reduces the initial removal of chylomicron remnants by rat liver but not the endocytosis of those remnants taken up (13) 
